Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic delay in patients with inflammatory bowel disease in Austria.
Novacek G, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Vogelsang H, Dejaco C, Waldhör T; Austrian IBD Study Group (ATISG). Novacek G, et al. Wien Klin Wochenschr. 2019 Mar;131(5-6):104-112. doi: 10.1007/s00508-019-1451-3. Epub 2019 Feb 4. Wien Klin Wochenschr. 2019. PMID: 30715607
Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
Scharrer S, Primas C, Eichinger S, Tonko S, Kutschera M, Koch R, Blesl A, Reinisch W, Mayer A, Haas T, Feichtenschlager T, Fuchssteiner H, Steiner P, Ludwiczek O, Platzer R, Miehsler W, Tillinger W, Apostol S, Schmid A, Schweiger K, Vogelsang H, Dejaco C, Herkner H, Novacek G; Austrian IBD Study Group. Scharrer S, et al. Inflamm Bowel Dis. 2021 Oct 20;27(11):1773-1783. doi: 10.1093/ibd/izaa337. Inflamm Bowel Dis. 2021. PMID: 33386735
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.
Kutschera M, Waldhör T, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Peters PG, Reicht G, Moser G, Dejaco C, Vogelsang H, Primas C, Novacek G, Miehsler W; Austrian IBD Study Group. Kutschera M, et al. United European Gastroenterol J. 2021 Feb;9(1):72-81. doi: 10.1177/2050640620946874. Epub 2021 Feb 18. United European Gastroenterol J. 2021. PMID: 32723070 Free PMC article.
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Kutschera M, Dejaco C, Vogelsang H, Novacek G; Austrian IBD Study Group (ATISG). Gröchenig HP, et al. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1211-1219. doi: 10.1097/MEG.0000000000001533. Eur J Gastroenterol Hepatol. 2019. PMID: 31498280
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial.
Blesl A, Borenich A, Gröchenig HP, Novacek G, Primas C, Reinisch W, Kutschera M, Illiasch C, Hennlich B, Steiner P, Koch R, Tillinger W, Haas T, Reicht G, Mayer A, Ludwiczek O, Miehsler W, Steidl K, Binder L, Baumann-Durchschein F, Fürst S, Reider S, Watschinger C, Wenzl H, Moschen A, Berghold A, Högenauer C; Austrian IBD Study Group (ATISG). Blesl A, et al. J Clin Med. 2023 Jul 24;12(14):4853. doi: 10.3390/jcm12144853. J Clin Med. 2023. PMID: 37510968 Free PMC article.